EUR 16.05
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 18.34 Million | 1.78 Million | 1.86 Million | 7.18 Million | 11.53 Million | 7.81 Million |
Net Income | 13.9 Million | 12.26 Million | 5.11 Million | 1.64 Million | 8.66 Million | 9.32 Million |
Depreciation & Amortization | 2.17 Million | 2 Million | 2 Million | 2.18 Million | 2.29 Million | 1.41 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.34 Million | -16.26 Million | -6.06 Million | 4.71 Million | -417 Thousand | -2.42 Million |
Other non-cash items | 484.95 Thousand | 1.33 Million | -129.95 Thousand | 605.24 Thousand | -359 Thousand | -505.32 Thousand |
Investing Cash Flow | -434.03 Thousand | -17.47 Thousand | -3.14 Million | -452.37 Thousand | -2.09 Million | -2.52 Million |
Investments in PPE | -1.3 Million | -888.31 Thousand | -598.79 Thousand | -462.8 Thousand | -1.21 Million | -841 Thousand |
Acquisitions | -1.11 Million | - | 50 Thousand | - | - | - |
Investment purchases | -1.48 Million | -39.54 Thousand | -6.56 Million | - | -1.35 Million | - |
Sales/Maturities of investments | 3.46 Million | 910.38 Thousand | 3.97 Million | 10.42 Thousand | 478 Thousand | - |
Other Investing Activities | -1.00 | 660.7 Thousand | -1.00 | -135.54 Thousand | -1000.00 | -1.68 Million |
Financing Cash Flow | -11.35 Million | -4.49 Million | -4.06 Million | 1.72 Million | -7.02 Million | -5.7 Million |
Debt repayment | -5.63 Million | -723.16 Thousand | -144.62 Thousand | -4.01 Million | -18 Thousand | -1.2 Million |
Dividends payments | -6.5 Million | -3.47 Million | -2.84 Million | - | -5.49 Million | -4.6 Million |
Common Stock Repurchased | - | -470.93 Thousand | -109.62 Thousand | -1.04 Million | -262 Thousand | - |
Common Stock Issuance | 2.11 Million | - | - | - | - | - |
Other Financing Activities | 1.00 | - | -1.00 | - | -1.24 Million | 106 Thousand |
Accounts receivables | 6.24 Million | -9.73 Million | -6.66 Million | 4.9 Million | 543 Thousand | -1.41 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | 729.57 Thousand | -9.09 Million | -5.07 Million | 1.23 Million | 509 Thousand | -786 Thousand |
Other working capital | -221.67 Thousand | -40.85 Thousand | -7888.00 | -154.13 Thousand | - | -219 Thousand |
Cash at beginning of period | 5.34 Million | 8.07 Million | 13.41 Million | 4.96 Million | 2.54 Million | 2.96 Million |
Cash at end of period | 11.9 Million | 5.34 Million | 8.07 Million | 13.41 Million | 4.96 Million | 2.54 Million |
Capital Expenditure | -1.3 Million | -888.31 Thousand | -598.79 Thousand | -462.8 Thousand | -1.21 Million | -841 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 6.55 Million | -2.72 Million | -5.34 Million | 8.45 Million | 2.41 Million | -420 Thousand |
Free Cash Flow | 17.03 Million | 894.09 Thousand | 1.26 Million | 6.71 Million | 10.31 Million | 6.96 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 8.47 Million | 3.25 Million | 2.32 Million | 13.9 Million | 3.55 Million | 4.06 Million |
Depreciation & Amortization | - | - | - | 2.17 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 1.34 Million | - | - |
Other non-cash items | -8.47 Million | -3.25 Million | -2.32 Million | 484.95 Thousand | -3.55 Million | -4.06 Million |
Investing Cash Flow | - | - | - | -434.03 Thousand | - | - |
Investments in PPE | - | - | - | -1.3 Million | - | - |
Acquisitions | - | - | - | -1.11 Million | - | - |
Investment purchases | - | - | - | -1.48 Million | - | - |
Sales/Maturities of investments | - | - | - | 3.46 Million | - | - |
Other Investing Activities | - | - | - | -1.00 | - | - |
Financing Cash Flow | - | - | - | -11.35 Million | - | - |
Debt repayment | - | - | - | -5.63 Million | - | - |
Dividends payments | - | - | - | -6.5 Million | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 2.11 Million | - | - |
Other Financing Activities | - | - | - | 1.00 | - | - |
Accounts receivables | - | - | - | 6.24 Million | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | 729.57 Thousand | - | - |
Other working capital | - | - | - | -221.67 Thousand | - | - |
Cash at beginning of period | - | - | - | 5.34 Million | - | - |
Cash at end of period | - | - | - | 11.9 Million | - | - |
Capital Expenditure | - | - | - | -1.3 Million | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 6.55 Million | - | - |
Free Cash Flow | - | - | - | 17.03 Million | - | - |
APCOTEXIND
688767
PHRRF
PANS
GKP
DOC